LBT Innovations (LBT) Stock Price, News & Analysis

Company Overview

LBT Innovations Limited engages in the research, development, and commercialization of technologies for the healthcare and laboratory supply markets in Australia, the United States, Sweden, the United Kingdom, and Germany. Its products portfolio comprises Automated Plate Assessment System (APAS) Independence, a platform technology that automates culture-plate screening and interpretation; APAS Analysis Modules, an intelligent image analysis software that enables the screening of microbiology culture plates; APAS antimicrobial resistance (AMR) Analysis Module that reads and interprets antimicrobial susceptibility tests (ASTs) for the detection of AMR; and APAS PharmaQC, which provides automated imaging, analysis, and interpretation of microbiology culture plates used in environmental monitoring. The company's products pipeline also includes Automated Gram Strain Assessment for the automated interpretation of gram stain image analysis; Biofilm, a device for detecting the biofilms in the presence of mammalian tissues; and WoundVue, a technology that uses artificial intelligence to assist clinicians in the assessment and care of chronic wounds. LBT Innovations Limited was incorporated in 2004 and is headquartered in Adelaide, Australia.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 857,080 shs
• Average Volume: N/A
• Market Capitalization: A$29.89 million
• P/E Ratio: N/A
• Dividend Yield: 10.81%
• Price Target: N/A
• Consensus Rating: N/A

LBT Stock Analysis - Frequently Asked Questions

How were LBT Innovations' earnings last quarter?

LBT Innovations Limited (ASX:LBT) announced its quarterly earnings data on Tuesday, February, 26th. The company reported ($0.01) earnings per share (EPS) for the quarter. LBT Innovations had a negative net margin of 297.77% and a negative trailing twelve-month return on equity of 150.35%.

What other stocks do shareholders of LBT Innovations own?

Based on aggregate information from My MarketBeat watchlists, some other companies that LBT Innovations investors own include Allied Gaming & Entertainment (AGAE), Avino Silver & Gold Mines (ASM), Academy Sports and Outdoors (ASO), Berkeley Energia (BKY), Global X Cloud Computing ETF (CLOU), VelocityShares 1x Long VSTOXX Futures ETN (EVIX) and First Trust United Kingdom AlphaDEX Fund (FKU).

Company Calendar

• Last Earnings: 2/26/2019
• Today: 7/19/2025

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Medical
• Industry: Medical Devices
• Sub-Industry: N/A
• Current Symbol: ASX:LBT
• CIK: N/A
• Web: www.lbtinnovations.com
• Phone: 61 8 8227 1555
• Fax: N/A
• Employees: 19
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -A$3.74 million
• Net Margins: -297.77%
• Pretax Margin: N/A
• Return on Equity: -150.35%
• Return on Assets: -38.72%

Debt

• Debt-to-Equity Ratio: 71.94
• Current Ratio: 3.62
• Quick Ratio: 2.10

Sales & Book Value

• Annual Sales: A$1.26 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 4.19
• Book Value: A$0.00 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 1,750,000,000
• Free Float: N/A
• Market Cap: A$29.89 million
• Optionable: Not Optionable
• Beta: 1.88